Please assess the completion status of the following clinical trial:

Trial Title: Furosemide for Accelerated Recovery of Blood Pressure Postpartum

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hypertensive disorder of pregnancy diagnosed antepartum or intrapartum~* Gestational hypertension~* Pre-eclampsia with or without severe features~* Superimposed pre-eclampsia with or without severe features~* New diagnosis of HDP within 24 hours from delivery~* Postpartum, delivery ≥ 20 weeks estimated gestational age~* Age ≥18 years old~Exclusion Criteria:~* History of allergic reaction to furosemide~* High risk comorbidities for which treatment may be indicated or contraindicated: class C or higher diabetes mellitus, chronic kidney disease or baseline creatinine \>1.2, cardiac disorders including cardiomyopathy, congenital heart disease, angina or coronary heart disease, rheumatic disease (lupus), sickle cell disease~* Baseline labs with K \<3~* Use of furosemide or other diuretics antepartum or intrapartum~* Use of ototoxic agents including aminoglycosides (ie, Gentamicin for \>1 dose), cephalosporins (ie Ancef \>1 dose),~* Patient unstable for protocol per investigator's judgement

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Oral furosemide (Type: EXPERIMENTAL): Oral furosemide 20 mg/day for a total of 5 consecutive doses.
- Placebo Oral Tablet (Type: PLACEBO_COMPARATOR): Placebo once per day for a total of 5 consecutive doses.

Based on this trial design, predict the completion outcome and termination type (if applicable).